Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by alainmange
Group name PlateformePP2I
Item Type Journal Article
Title Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor
Creator Bianga et al.
Author Juliusz Bianga
Author Amina Bouslimani
Author Nicole Bec
Author Sandra Mounicou
Author Joanna Szpunar
Author Brice Bouyssiere
Author Ryszard Lobinski
Author Christian Larroque
Abstract The follow-up of the Heated Intraoperative Chemotherapy (HIPEC) of peritoneal carcinomatosis would benefit from the monitoring of the penetration, distribution and metabolism of the drug within the tumor. As tumor nodules can be resected during the therapy, mass spectrometry imaging is a suitable tool for the evaluation of treatment efficacy, and, as a result, the therapy can be re-optimized. In this work we demonstrate the complementarity of laser ablation (LA) ICP mass spectrometry and MALDI imaging to study the penetration and distribution of two Pt-based metallodrugs (cisplatin and oxaliplatin) in human tumor samples removed from patients diagnosed with colorectal or ovarian peritoneal carcinomatosis. LA ICP MS offered sensitive (LOD for (195)Pt 4.8 pg s(-1)) imaging of platinum quasi-independently of the original species and the sample matrix and thus an ultimate way of verifying the penetration of the Pt-containing drug or its moieties into the tumor. MALDI imaging was found to suffer in some cases from signal suppression by the matrix leading to false negatives. In the case of the oxaliplatin metallodrug, the results obtained from ICP and MALDI MS imaging were coherent whereas in the case of cisplatin, species detected by ICP MS imaging could not be validated by MALDI MS. The study is the first application of the dual ICP and MALDI MS imaging to the follow-up of metallodrugs in human tumors.
Publication Metallomics: Integrated Biometal Science
Volume 6
Issue 8
Pages 1382-1386
Date Aug 2014
Journal Abbr Metallomics
Language eng
DOI 10.1039/c4mt00131a
ISSN 1756-591X
Library Catalog PubMed
Extra PMID: 24984817
Tags author, Cisplatin, Female, Humans, last, Organoplatinum Compounds, original, Ovarian Neoplasms, Platinum, pp2i, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Date Added 2019/06/04 - 17:36:14
Date Modified 2020/01/14 - 10:26:56


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés